Centurion Acquisition (NASDAQ:ALF) Share Price Breaks Below 200 Day Moving Average – Time to Sell?

Centurion Acquisition Corp. (NASDAQ:ALF)’s share price passed below its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $10.81 and traded as low as $10.80. Centurion Acquisition shares last traded at $10.80, with a volume of 61 shares trading hands.

Analyst Ratings Changes

Separately, Weiss Ratings raised Centurion Acquisition from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, September 4th. One investment analyst has rated the stock with a Hold rating. Based on data from MarketBeat.com, the company has a consensus rating of “Hold”.

Centurion Acquisition Stock Down 1.4%

The company has a fifty day moving average price of $10.84 and a two-hundred day moving average price of $10.81.

Institutional Investors Weigh In On Centurion Acquisition

A number of institutional investors have recently added to or reduced their stakes in ALF. Context Capital Management LLC acquired a new stake in shares of Centurion Acquisition in the third quarter valued at about $5,410,000. Citadel Advisors LLC acquired a new position in Centurion Acquisition during the second quarter worth about $130,000. Sona Asset Management US LLC acquired a new position in Centurion Acquisition during the first quarter worth about $1,092,000. Finally, Berkley W R Corp grew its position in Centurion Acquisition by 376.0% during the first quarter. Berkley W R Corp now owns 1,157,544 shares of the company’s stock worth $12,455,000 after buying an additional 914,380 shares during the period.

Centurion Acquisition Company Profile

Centurion Acquisition Corp. (NASDAQ: ALF) was a special purpose acquisition company (SPAC), also known as a blank-check company. Its primary purpose was to raise capital through a public offering and use the proceeds to pursue a merger, acquisition, or similar business combination with an operating company. Unlike an operating company, Centurion Acquisition did not have an established portfolio of products or services, manufacturing operations, or a defined customer base. Its activities centered on evaluating potential acquisition targets, negotiating a transaction, and completing the related regulatory and shareholder approval processes.